Discover why pharma sector leaders and AI innovation may drive the S&P 500 to 9,000 by 2026. Explore top stocks, growth ...
The company monitors passenger feedback for risky driver behavior. Some accused of serious sexual assault had prior records ...
Caliway Biopharmaceuticals completes submission of IND application to US FDA for phase 2 study of CBL-514 for weight management: New Taipei City Monday, December 29, 2025, 11:00 H ...
BEIJING, Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ('iHuman' or the 'Company'), a leading provider of tech-powered ...
NDA supported by results from a Phase II registration trial in China —— Second most common form of liver cancer after hepatocellular carcinoma, ...
Did you miss the most popular gastroenterology stories this year? Medscape Medical News tracked the news most popular with ...
The Greek Documentary Festival (DocFest) in Chalkida pays tribute to the Greek community of Australia, highlighting diasporic ...
The Museum of Contemporary Art has announced its 2026 exhibition schedule, a combination of bold commissions, collaborations ...
EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...
(Alliance News) - Hutchmed China Ltd on Monday said Chinese regulators have accepted a new drug application for its cancer treatment fanregratinib and granted it priority review status.
Maintaining good oral hygiene, regular exercise and increasing your social interactions can help prevent or delay the onset of dementia This is the 79th instalment in a series on dementia, including ...
The Centro Escolar University (CEU) School of Dentistry proudly marked its 100th anniversary with a landmark celebration honoring a century of academic excellence, service, and leadership in dental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback